Skip to main content

Near Infrared Spectroscopy

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nonin
NoninMN - Plymouth
1 program
Comparison of Normal Readings and Repeatability Across Skin ColorsN/A1 trial
Active Trials
NCT01326819Completed231Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NoninComparison of Normal Readings and Repeatability Across Skin Colors

Clinical Trials (1)

Total enrollment: 231 patients across 1 trials

NCT01326819NoninComparison of Normal Readings and Repeatability Across Skin Colors

Comparison of Normal Readings and Repeatability Across Skin Colors

Start: Mar 2011Est. completion: Dec 2012231 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.